🔎 Trials Near Me

Akèy › Ensifizyans kadyak › Kalifòni › San Francisco

Etid klinik pou Ensifizyans kadyak nan San Francisco, CA

29 etid pou Ensifizyans kadyak ap chèche patisipan nan sit nan ak bò kote San Francisco (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

ELEVATE-HFpEF Clinical Study

Ap rekrite
  • Sutter Health Hospital, San Francisco
Laj 40 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT06678841

Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function

Ap rekriteFaz 3
  • Research Site, San Francisco
Laj 18 a 130 · Tout sèks · Mizajou Oct 2, 2026 · NCT06307652

A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy

Ap rekriteFaz 2
  • University of California, San Francisco, San Francisco
  • University of California San Francisco UCSF, San Francisco
Laj 40 a 84 · Tout sèks · Mizajou Sep 30, 2026 · NCT06979362

Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction

Ap rekriteFaz 3
  • California Pacific Medical Center Van Ness Campus, San Francisco
Laj 18 a 85 · Tout sèks · Mizajou Sep 24, 2026 · NCT06736574

Alleviant ALLAY-HFrEF Study

Ap rekrite
  • University of California San Francisco, San Francisco
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT06812533

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

Ap rekriteFaz 3
  • Kaiser Permanente, San Francisco
Laj 18 a 99 · Tout sèks · Mizajou Sep 16, 2026 · NCT07037459

Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin

Ap rekriteFaz 3
  • Research Site, San Francisco
Laj 40 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT06677060

A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)

Ap rekriteFaz 3
  • San Francisco, CA Investigative Site CON-10315, San Francisco
  • CON-10023, San Francisco, CA, San Francisco
Laj 18 ak plis · Tout sèks · Mizajou Sep 10, 2026 · NCT06024746

A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients

Ap rekriteFaz 3
  • San Francisco, CA Investigative Site 10023, San Francisco
Laj 18 ak plis · Tout sèks · Mizajou Sep 10, 2026 · NCT06008197

Remote Dielectric Sensing (ReDS) Assisted Diuresis in Acute Decompensated Heart Failure

Ap rekrite
  • University of California, San Francisco, San Francisco
Laj 18 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT03586336

AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF

Ap rekriteFaz 2
  • University of California, San Francisco - Heart and Vascular Center, San Francisco
Laj 40 a 85 · Tout sèks · Mizajou Aug 27, 2026 · NCT06793371

Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure

Ap rekrite
  • Zuckerberg San Francisco General, San Francisco
  • University of California San Francisco, San Francisco
Laj 21 ak plis · Tout sèks · Mizajou Aug 25, 2026 · NCT05677100

LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2

Ap rekriteFaz 3
  • Tenax Investigational Site, San Francisco
Laj 18 a 85 · Tout sèks · Mizajou Aug 19, 2026 · NCT07288398

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

Ap rekriteFaz 3
  • Kaiser Permanente Northern California, San Francisco
  • San Francisco V.A. Medical Center, San Francisco
Laj 18 ak plis · Tout sèks · Mizajou Aug 18, 2026 · NCT07567001

Alleviant ALLAY-HF Study

Ap rekrite
  • University of California San Francisco, San Francisco
Laj 40 ak plis · Tout sèks · Mizajou Aug 14, 2026 · NCT05685303

Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia

Ap rekriteFaz 3
  • UC San Francisco Medical Center, San Francisco
Laj 2 a 11 · Tout sèks · Mizajou Jul 24, 2026 · NCT06597006

A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists

Ap rekriteFaz 3
  • San Francisco, CA Investigative Site FIN-10023, San Francisco
Laj 18 ak plis · Tout sèks · Mizajou Jul 10, 2026 · NCT06033950

PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III

Ap rekrite
  • UCSF Medical Center, San Francisco
Laj 18 ak plis · Tout sèks · Mizajou Jun 29, 2026 · NCT05934487

Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure

Ap rekrite
  • University of California at San Francisco, San Francisco
Laj 18 ak plis · Tout sèks · Mizajou Jun 10, 2026 · NCT06526195

Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia

Ap rekriteFaz 3
  • UC San Francisco Medical Center, San Francisco
  • UC San Francisco Medical Center, San Francisco
Laj 6 a 11 · Tout sèks · Mizajou May 15, 2026 · NCT06597019

Developing a Digital Aid to Improve ICD Decisions

Ap rekrite
  • University of California, San Francisco, San Francisco
Laj 60 ak plis · Tout sèks · Mizajou Apr 27, 2026 · NCT07084142

The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR

Ap rekrite
  • University of California- San Francisco, San Francisco
Laj 18 ak plis · Tout sèks · Mizajou Apr 13, 2026 · NCT03142152

Voice Analysis to Detect Pulmonary Arterial Pressure Changes in Heart Failure

Ap rekriteEtid obsèvasyon
  • University of California, San Francisco (UCSF), San Francisco
Laj 18 ak plis · Tout sèks · Mizajou Mar 2, 2026 · NCT07443670

Human/Machine Interface: What the HeartMate 3 ® Device Tells Us About the Future

Ap rekriteEtid obsèvasyon
  • UCSF, San Francisco
Laj 18 a 100 · Tout sèks · Mizajou Dec 16, 2025 · NCT06039176

AN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE CORDIO HEARO SYSTEM

Ap rekriteEtid obsèvasyon
  • University of California, San Francisco, San Francisco
  • Kaiser Permanente San Francisco, San Francisco
Laj 22 ak plis · Tout sèks · Mizajou Mar 26, 2025 · NCT06378632

Open-label, Dose Escalation Study of Safety and Preliminary Efficacy of TN-401 in Adults With PKP2 Mutation-associated ARVC

Ap rekriteFaz 1
  • University of California San Francisco, San Francisco
Laj 18 a 65 · Tout sèks · Mizajou Feb 6, 2025 · NCT06228924

Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction

Ap rekriteFaz 1/2
  • University of California, San Francisco, San Francisco
Laj 18 a 80 · Tout sèks · Mizajou Mar 26, 2024 · NCT04703842

Etid Ensifizyans kadyak nan lòt vil

Lòt etid nan San Francisco

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.